Ahmad Najem Selected Research

melanogenin

7/2018

Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmad Najem Research Topics

Disease

14	Melanoma (Melanoma, Malignant) 01/2022 - 03/2016
6	Neoplasms (Cancer) 01/2021 - 12/2017
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Fibrosarcoma 01/2020

Drug/Important Bio-Agent (IBA)

4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2020 - 03/2016
4	Drug CombinationsIBA 12/2017 - 03/2016
3	VemurafenibIBA 08/2019 - 03/2016
2	Phosphotransferases (Kinase)IBA 04/2021 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 04/2021 - 01/2020
2	venetoclaxIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 08/2018
2	Proteins (Proteins, Gene)FDA Link 05/2020 - 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	tyrosine receptor (receptor, tyrosine)IBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2021
1	Proto-Oncogene Proteins c-metIBA 04/2021
1	Growth Factor ReceptorsIBA 04/2021
1	Melanins (Melanin)IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Amphibian VenomsIBA 08/2020
1	Adenosine Triphosphatases (ATPase)IBA 08/2020
1	bufalinIBA 08/2020
1	BufanolidesIBA 08/2020
1	Cardiac GlycosidesIBA 08/2020
1	VenomsIBA 08/2020
1	Complex MixturesIBA 08/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Free RadicalsIBA 08/2019
1	Sulfhydryl Compounds (Thiols)IBA 08/2019
1	GalactosidasesIBA 08/2018
1	ProhibitinsIBA 07/2018
1	LigandsIBA 07/2018
1	melanogeninIBA 07/2018
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 12/2017
1	Microphthalmia-Associated Transcription FactorIBA 01/2017
1	Cytostatic AgentsIBA 01/2017
1	eprenetapoptIBA 03/2016

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2016
1	Radiotherapy 08/2019